Greenwich LifeSciences, Inc. (GLSI) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	10-K	S-1
Revenue
Operating expenses
Research and development	6.5	3.6	1.1	2.6	1.3
General and administrative	1.6	1.0	0.8	0.8	0.4
Total operating expenses	8.0	4.6	1.9	3.4	1.7
Loss from operations	-8.0	-4.6	-1.9	-3.4	-1.7
Interest Income	0.2	0.0	0.0
Net loss	-7.8	-4.6	-1.9	-3.4	-1.7

Per share information:
Net loss per common share, basic	($0.61)	($0.35)	($0.20)	($1.52)	($8.32)
Net loss per common share, diluted	($0.61)	($0.35)	($0.20)	($1.52)	($8.32)
Weighted average common shares outstanding, basic	12.9	12.9